Hyubis Tablet
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
(Ltd.) Hyubist Pharmaceutical
MFDS item code 201904805 · Approved 2019.07.18
This product's status changed to Expired on 2024.07.18. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of gastrointestinal diseases (ulcers, gastritis, gastroesophageal reflux disease, etc.), prevention of Mendelson syndrome
This medication is used for gastrointestinal diseases such as gastric and duodenal ulcers, gastritis, and gastroesophageal reflux disease. It is also effective for conditions associated with excessive gastric acid secretion such as Zollinger-Ellison syndrome, and helps prevent postoperative ulcers and treat ulcers induced by NSAIDs (non-steroidal anti-inflammatory drugs). It is utilized for preventing Mendelson's syndrome when administered before anesthesia. This medication suppresses gastric acid secretion, providing comfort to the stomach and alleviating symptoms.
○ Adults The usual dose is 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 4 tablets twice daily, in the morning and at bedtime. The dose is the same for ulcers caused by nonsteroidal anti-inflammatory drugs or for concomitant use to prevent gastric or duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug administration usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. In patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times daily and increase the dose if necessary. In severe cases, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions Once oral administration is possible, switch from injection to oral administration and give 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets on the night before surgery.
This medication should not be used by patients undergoing dialysis or those with renal function issues. Additionally, it should not be administered to patients with a history of allergy to this drug or its components, those with a history of acute porphyria, patients who have undergone upper gastrointestinal surgery, pregnant women or those who may become pregnant, premature infants or newborns, and patients who need to restrict potassium intake. Patients with liver function impairment, a history of drug allergies, the elderly, those with a history of renal function decline, and patients taking NSAIDs should exercise special caution when using this medication. Particularly, since it can mask symptoms of gastric cancer, patients over middle age with recent onset of gastric ulcer or dyspeptic symptoms should confirm the absence of malignant diseases prior to treatment. This medication should be used in conjunction with eradication therapy for patients with Helicobacter pylori infection causing gastric and duodenal ulcers, and it needs to be administered cautiously in severely ill patients in the intensive care unit or those with hypophosphatemia, and patients with dysphagia. During the use of this medication, rare but severe allergic reactions, skin rashes, reduction in blood cell counts, liver function abnormalities, arrhythmias, gastrointestinal symptoms, neurological symptoms, muscle pain, hair loss, etc., may occur. If any abnormal symptoms arise, discontinue use immediately and consult a physician. Long-term use is not recommended, and if no therapeutic effect is observed, switching to another medication should be considered. Elderly patients or those with chronic lung disease or diabetes may have an increased risk of pneumonia, thus caution is necessary. Dizziness or drowsiness may occur, so it is advisable to avoid driving or operating hazardous machinery. This medication can interact with other drugs, so it is essential to consult with a healthcare professional if you are taking anticoagulants or certain antibiotics or anticonvulsants. Pregnant or nursing women should not use this drug, and safety in children has not been established, thus administration to children is not advisable. In case of overdose, emergency treatments such as vomiting or gastric lavage may be needed, and blood dialysis may be performed if necessary. Finally, as this medication reduces gastric acid secretion, it may promote bacterial growth in the stomach, so it is advisable to undergo eye examinations with long-term use.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air ingress, and it is important to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature. Proper storage will help maintain the effectiveness of the medication for a longer period.
Green round film-coated tablets
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
(Ltd.) Hyubist Pharmaceutical
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.